Cargando…

Taking patient reported outcomes centre stage in cancer research – why has it taken so long?

PLAIN ENGLISH SUMMARY: Roger Wilson challenged cancer professionals in research and care to place the patient perspective and patient reported outcome measures centre stage. The ability to collect information from patients using structured questionnaires (known as Patient Reported Outcome Measures o...

Descripción completa

Detalles Bibliográficos
Autores principales: Selby, Peter, Velikova, Galina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052546/
https://www.ncbi.nlm.nih.gov/pubmed/30038798
http://dx.doi.org/10.1186/s40900-018-0109-z
_version_ 1783340676349427712
author Selby, Peter
Velikova, Galina
author_facet Selby, Peter
Velikova, Galina
author_sort Selby, Peter
collection PubMed
description PLAIN ENGLISH SUMMARY: Roger Wilson challenged cancer professionals in research and care to place the patient perspective and patient reported outcome measures centre stage. The ability to collect information from patients using structured questionnaires (known as Patient Reported Outcome Measures or PROMs) which ask about clinical issues (such as disease symptoms or treatment side-effects) as well as social, emotional and psychological issues has existed for 40 years. They provide a powerful way of working out whether an aspect of diagnosis or treatment for cancer is bringing real benefits to patients that can be measured using these structured questionnaires. When they are used, studies and cancer service developments are clearly constrained to focus on what matters to patients rather than, perhaps what matters to health service professionals or recent exciting but perhaps relatively unproven new technologies. There is good evidence that PROMs can contribute valuable inputs into the results of randomised controlled trials, clinical consultations and surveys of whole populations even at a national level. However, there is a great deal more work to be done on methodology and perhaps to change attitudes and cultures within the healthcare professions before they can deliver all of their potential to bring benefits to cancer patients. ABSTRACT: In response to Roger Wilson’s challenge to place a patient-centred approach using Patient Reported Outcome Measures (PROMs) across all of the patient pathway, we have summarised progress over 40 years. We have critically evaluated what has been achieved to use patient reported outcomes in randomised controlled trials, in routine clinical practice and in population surveys. We conclude that there has been substantial scientific progress but that it has, arguably, been relatively slow. Barriers to placing PROMs centre stage in all of these areas of activity remain in methodology and to a degree in professional attitudes and culture. Active research programmes on methodology and closer working between healthcare professionals, cancer patients and patient advocates are the key requirements to speed up the use and application of PROMs and which should bring benefits to cancer patients and healthcare services.
format Online
Article
Text
id pubmed-6052546
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60525462018-07-23 Taking patient reported outcomes centre stage in cancer research – why has it taken so long? Selby, Peter Velikova, Galina Res Involv Engagem Letter PLAIN ENGLISH SUMMARY: Roger Wilson challenged cancer professionals in research and care to place the patient perspective and patient reported outcome measures centre stage. The ability to collect information from patients using structured questionnaires (known as Patient Reported Outcome Measures or PROMs) which ask about clinical issues (such as disease symptoms or treatment side-effects) as well as social, emotional and psychological issues has existed for 40 years. They provide a powerful way of working out whether an aspect of diagnosis or treatment for cancer is bringing real benefits to patients that can be measured using these structured questionnaires. When they are used, studies and cancer service developments are clearly constrained to focus on what matters to patients rather than, perhaps what matters to health service professionals or recent exciting but perhaps relatively unproven new technologies. There is good evidence that PROMs can contribute valuable inputs into the results of randomised controlled trials, clinical consultations and surveys of whole populations even at a national level. However, there is a great deal more work to be done on methodology and perhaps to change attitudes and cultures within the healthcare professions before they can deliver all of their potential to bring benefits to cancer patients. ABSTRACT: In response to Roger Wilson’s challenge to place a patient-centred approach using Patient Reported Outcome Measures (PROMs) across all of the patient pathway, we have summarised progress over 40 years. We have critically evaluated what has been achieved to use patient reported outcomes in randomised controlled trials, in routine clinical practice and in population surveys. We conclude that there has been substantial scientific progress but that it has, arguably, been relatively slow. Barriers to placing PROMs centre stage in all of these areas of activity remain in methodology and to a degree in professional attitudes and culture. Active research programmes on methodology and closer working between healthcare professionals, cancer patients and patient advocates are the key requirements to speed up the use and application of PROMs and which should bring benefits to cancer patients and healthcare services. BioMed Central 2018-07-19 /pmc/articles/PMC6052546/ /pubmed/30038798 http://dx.doi.org/10.1186/s40900-018-0109-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Selby, Peter
Velikova, Galina
Taking patient reported outcomes centre stage in cancer research – why has it taken so long?
title Taking patient reported outcomes centre stage in cancer research – why has it taken so long?
title_full Taking patient reported outcomes centre stage in cancer research – why has it taken so long?
title_fullStr Taking patient reported outcomes centre stage in cancer research – why has it taken so long?
title_full_unstemmed Taking patient reported outcomes centre stage in cancer research – why has it taken so long?
title_short Taking patient reported outcomes centre stage in cancer research – why has it taken so long?
title_sort taking patient reported outcomes centre stage in cancer research – why has it taken so long?
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052546/
https://www.ncbi.nlm.nih.gov/pubmed/30038798
http://dx.doi.org/10.1186/s40900-018-0109-z
work_keys_str_mv AT selbypeter takingpatientreportedoutcomescentrestageincancerresearchwhyhasittakensolong
AT velikovagalina takingpatientreportedoutcomescentrestageincancerresearchwhyhasittakensolong